Market Update: Merck & Co Inc (NYSE:MRK) – Indian court bars Glenmark from selling Merck drug copies

[Reuters] – India’s Supreme Court has barred Glenmark Pharmaceuticals from making and selling copies of U.S. drugmaker Merck’s diabetes drugs Januvia and Janumet, according to a court document released on Friday. The court . . . → Read More: Market Update: Merck & Co Inc (NYSE:MRK) – Indian court bars Glenmark from selling Merck drug copies Similar Articles: Company Update: Merck & Co Inc (NYSE:MRK) – Merck Reaffirms Continued Commitment to Developing Innovative Medicines for the Treatment of Infectious Diseases at 25th Annual ECCMID Congress Market Update (NYSE:MRK): Merck Announces Collaboration with the American Diabetes Association to Educate Adults with Diabetes About Increased Risk for Serious Diseases like Pneumococcal Pneumonia Company Update (NYSE:LLY): Lilly delays submission to market once-daily diabetes drug